about
Hallucinations in schizophrenia and Parkinson's disease: an analysis of sensory modalities involved and the repercussion on patients.Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set.Amphiphilic properties of dumbbell-shaped inorganic-organic-inorganic molecular hybrid materials in solution and at an interface.Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease.A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap.Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care.Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort.Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.[Trauma and post-traumatic stress disorder in schizophrenia].Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.[Clozapine-induced parotitis: a case study].Depression in schizophrenia: the influence of the different dimensions of insight.Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.Factors predictive of medication nonadherence after renal transplantation: a French observational study.Towards a reconceptualization of mixed states, based on an emotional-reactivity dimensional model.Factors influencing compulsory admission in first-admitted subjects with psychosis.The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.Pattern of health service utilization and predictors of readmission after a first admission for psychosis: a 2-year follow-up study.Pathways to care of first-admitted subjects with psychosis in South-Western France.Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohortMetabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in SchizophreniaInflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohortDetermination of Adherence Profiles in Schizophrenia Using Self-Reported AdherenceMediation Analyses of Insight, Quality of Life, Depression, and Suicidality
P50
Q30367997-5CA7E477-C164-41C3-BA5B-424EF19D2534Q31032422-4B291015-D4DD-49AC-80A9-25DF6D6E2DEDQ31111007-F4D794A5-916A-406F-8553-EFACFB601B71Q33929166-64FFBCEC-2CB1-44D7-B6E9-DA080D5EFFA2Q36324947-17446E49-5511-4F25-8AAC-5E311FA00C75Q38284123-360AA4F3-05B6-450D-8F52-38D60343629BQ38389166-4F5A7139-36D2-43EB-BDE9-30E4AF937AA0Q38392954-D525A4CA-5542-467A-B256-2035772D2D65Q38435244-68BD2E12-16C9-49B2-A2C1-5E6A5747F088Q38437886-3D5AB868-D022-4423-8FCD-46260B2E8FAEQ38628702-3672C9DA-C1F1-443E-85FA-D6517D4962B7Q38664021-42DB424D-F9E8-48CC-99D6-4E39E0CD3739Q40512185-22FCA5B4-E9F5-45BB-B8BB-8120F7DEFAF8Q40525039-46C53AB8-BD04-4674-AE38-8EE28FC9E781Q41078160-CF1FEDF8-F5D8-4AA5-B04A-38234B8F2617Q43575082-5F01E1D4-1FEB-48E0-8BAD-22DB7212A3BEQ44921783-3970DD3F-C993-4A5D-AEBE-D7AF84566865Q47327369-362010CA-C882-4C07-AB51-0264BB057ED6Q47582903-8B9AAC80-E588-4083-A225-33CD616E12D6Q47714758-D293002B-2BED-4966-ADBE-73AD38D9BDD5Q47734278-A5A136F3-2644-44E5-ACD8-3142193DDB85Q47760005-D143063B-0B2D-49C0-A384-7A1FF82D0527Q47916586-BDDA132E-8AD0-4E3D-AADD-8A94D40431BEQ47921866-F9CAF8C6-7D40-4ABB-A0D7-462689222B6CQ47988538-ED02798A-A4CC-4D14-9807-A4AC76827095Q48111838-D14889A2-C3AC-4C37-A912-54D8F2CF2BE6Q50188670-EE5D3F86-413D-4273-A454-DAA725A8ED97Q50553941-D01C1D9A-A037-4D02-B736-92B04BEB04E3Q50775764-ACFD958F-15CD-411E-9A4F-58BC31AB82EFQ50912233-E4B3A63D-DF2A-43CB-B675-80950C800EF1Q50980742-826D5310-2FF6-4D22-8EE9-F0ACF11DE5AAQ51872260-7FD4A4E3-BDD9-47E5-BC41-6143628A7315Q51918623-ED8482FD-B3DA-4B1F-A099-D3ECDCAFAC69Q51943133-768049AC-6B04-4B8A-B8A8-6947B3FED416Q52318182-47B13230-6FEA-4B3C-96B0-683C77C49A54Q57700276-F2234ECE-C203-4EB4-A06A-DD1EEE051DD1Q57700281-4D363156-7DC7-4B9D-80F2-1FD8A620F98FQ59784199-4CF35736-E913-49B9-82DB-624E89D4938FQ59784207-499F2E32-5F9A-421E-9CA3-40ADE60070E2Q62772772-DEFB681C-A86B-4918-B051-BB17C7A70530
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Misdrahi
@ast
David Misdrahi
@en
David Misdrahi
@es
David Misdrahi
@nl
David Misdrahi
@sl
type
label
David Misdrahi
@ast
David Misdrahi
@en
David Misdrahi
@es
David Misdrahi
@nl
David Misdrahi
@sl
prefLabel
David Misdrahi
@ast
David Misdrahi
@en
David Misdrahi
@es
David Misdrahi
@nl
David Misdrahi
@sl
P106
P21
P31
P496
0000-0003-1146-3206